Drug interactions: Keeping it straight

American Family Physician

Volumn 56, Issue 3, 1997, Pages 883-894

  Anastasio, Geraldine D ^a,b   Cornell, Katharine O ^a   Menscer, Darlyne ^a,b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIMETABOLITE; BENZODIAZEPINE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CIMETIDINE; CIPROFLOXACIN; CISAPRIDE; CLONIDINE; CORTICOSTEROID; CYCLOSPORIN; DIGOXIN; DIURETIC AGENT; ERYTHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; INSULIN; ITRACONAZOLE; LITHIUM; METRONIDAZOLE; MONOAMINE OXIDASE INHIBITOR; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

DRUG ABSORPTION; DRUG INDUCED DISEASE; DRUG INFORMATION; DRUG MECHANISM; DRUG METABOLISM; DRUG MIXTURE; ENZYME INHIBITION; HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; REVIEW; TREATMENT FAILURE;

CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HUMANS; PHARMACOKINETICS;

EID: 0030817063     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Kirk JK. Significant drug-nutrient interactions. Am Fam Physician 1995;51:1175-82, 1185.
2. Yamreudeewong W, Henann NE, Fazio A, Lower DL, Cassidy TG. Drug-food interactions in clinical practice. J Fam Pract 1995;40:376-84.
3. Goldberg RM, Mabee J, Mammone M, Chan L, Tarleton G, Broderick S, et al. A comparison of drug interaction software programs: applicability to the emergency department. Ann Emerg Med 1994;24:619-25.
4. Hansten PD, Horn JR. The top 40 drug interactions. Drug Interact Newslett 1991;11:483-90.
5. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman & Gilman's The pharmacological basis of therapeutics. 9th ed. New York: McGraw Hill, 1996.
6. Jankel CA, McMillan JA, Martin BC. Effect of drug interactions on outcomes of patients receiving warfarin or theophylline. Am J Hosp Pharm 1994;51:661-6.
7. Miller DM, Helms SE, Brodell RT. A practical approach to antibiotic treatment in women taking oral contraceptives. J Am Acad Dermatol 1994;30:1008-11.
8. Mills KC. Serotonin syndrome. Am Fam Physician 1995;52:1475-82.
9. Hansten PD, Horn LR, eds. Drug interactions analysis and management. Vancouver, Wash.: Applied Therapeutics, 1997.
10. Tatro DS, ed. Drug interaction facts. St. Louis: Lippincott, 1993.
11. Physicians' Desk Reference. CD-ROM. Montvale, N.J.: Medical Economics.
12. Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf 1993;9:51-9.
13. Mills KC. Essential emergency medicine pharmacokinetics: prevention of iatrogenic patient poisoning. Top Emerg Med 1993;14(4):18-29.
14. Koecheler JA, Abramowitz PW, Swim SE, Daniels CE. Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm 1989;46:729-32.
15. Marchbanks CR. Drug-drug interactions with fluoroquinolones. Pharmacotherapy 1993;13(2 Pt 2)23S-8S.
16. AHFS Drug information 96. Bethesda, Md.: American Society of Health-System Pharmacists, 1996.
17. Slaughter RL, Edwards DJ. Recent advances: the cytochrome P450 enzymes. Ann Pharmacother 1995;29:619-24.
18. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences. JAMA 1993;269:1513-8 [Published erratum appears in JAMA 1993;269:2088].
19. Amsden GW. Macrolides versus azalides: a drug interaction update. Ann Pharmacother 1995;29:906-17.
20. Horn JR, Hansten PD. Drug interactions with antibacterial agents. J Fam Pract 1995;41:81-90.
21. Physicians' desk reference: PDR, 1996. 50th ed. Montvale, N.J.: Medical Economics, 1996.
22. Ducharme MP, Slaughter RL, Warbasse LH, Chandrasekar PH, Van de Velde V, Mannens G, et al. Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin. Clin Pharmacol Ther 1995;58:617-24.
23. 4th American College of Chest Physicians Consensus Conference on Antithrombotic Therapy. Chest 1995;108(4 Suppl):225S-522S.
24. Herings RM, de Boer A, Stricker BH, Leufkens HG, Porsius A. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet 1995;345:1195-8.